| [11] |
Leong S,Christopherson RI,Baxter RC.Profiling of apoptotic changes in human breast cancer cells using SELDI-TOF mass spectrometry.Cell Physiol Biochem,2007,20:579-590.
|
| [12] |
Smith L,Welham KJ,Watson MB,et al.The proteomic analysis of cisplatin resistance in breast cancer cells.Oncol Res,2007,16:497-506.
|
| [13] |
Luo Y,Zhang J,Liu Y,et al.Comparative proteome analysis of breast cancer and normal breast.Mol Biotechnol,2005,29:233-244.
|
| [14] |
Deng S,Zhou H,Xiong R,et al.Over-expression of genes and proteins of ubiquitin specific pepidases(USPs)and proteasome subunits(PSs)in breast cancer tissue observed by the methods of RFDD-PCR and proteomics.Breast Cancer Res Treat,2007,104:21-30.
|
| [15] |
Zhang DH,Tai LK,Wong LL,et al.Proteomics of breast cancer:enhanced expression of cytokeratin19 in human epidermal growth factor receptor type 2 positive breast tumors.Proteomics,2005,5:1797-1805.
|
| [16] |
Vydra J,SelicharováI,SmutnáK,et al.Two-dimensional electrophoretic comparison of metastatic and nonmetastatic human breast tumors using in vitro cultured epithelial cells derived from the cancer tissues.BMC Cancer,2008,8:107.
|
| [17] |
Pawlik TM,Fritsche H,Coombes KR,et al.Significant differences in nipple aspirate fluid protein expression between healthy women and those with breast cancer demonstrated by time-of-flight mass spectrometry.Breast Cancer Res Treat,2005,89:149-157.
|
| [18] |
Alexander H,Stegner AL,Wagner-Mann C,et al.Proteomic analysis to identify breast cancer biomarkers in nipple aspirate fluid.Clin Cancer Res,2004,10:7500-7510.
|
| [19] |
Sauter ER,Zhu W,Fan XJ,et al.Proteomic analysis of nipple aspirate fluid to detect biologic markers of breast cancer.Br J Cancer,2002,86:1440-1443.
|
| [20] |
Paweletz CP,Trock B,Pennanen M,et al.Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF:potential for new biomarkers to aid in the diagnosis of breast cancer.Dis Markers,2001,17:301-307.
|
| [21] |
Kuerer HM,Coombes KR,Chen JN,et al.Association between ductal fluid proteomic expression profiles and the presence of lymph node metastases in women with breast cancer.Surgery,2004,136:1061-6019.
|
| [22] |
Streckfus CF,Mayorga-Wark O,Arreola D,et al.Breast cancer related proteins are present in saliva and are modulated secondary to ductal carcinoma in situ of the breast.Cancer Invest,2008,26:159-167.
|
| [1] |
Wasinger VC,Cordwell SJ,Cerpa-Poljak A,et a1.Progress with gene-product mapping of the mollicutes:mycoplasma genitalium.Electrophoresis,1995,16:1090-1094.
|
| [2] |
Alaoui-Jamali MA,Xu YJ.Proteomic technology for biomarker profiling in cancer:an update.J Zhejiang Univ SciB,2006,7:411-420.
|
| [3] |
Fu Q,Van Eyk JE.Proteomics and heart disease:identifying biomarkers of clinical utility.Expert Rev Proteomics,2006,3:237-249.
|
| [4] |
Hsieh SY,Chen RK,Pan YH,et al.Systematical evaluation of the effects of sample collection procedures on low molecular weight serum/plasma proteome profiling.Proteomics,2006,6:3189-3198.
|
| [5] |
Villanueva J,Shaffer DR,Philip J,et al.Differential exoprotease activities confer tumor-specific serum peptidome patterns.J Clin Ivest,2006,116:271-284.
|
| [6] |
Goncalves A,Esterni B,Bertucci F,et al.Postoperative serum proteomic profiles may predict metastatic relapse in high-risk primary breast cancer patients receiving adjuvant chemotherapy.Oncogene,2006,23:291-292.
|
| [7] |
Li J,Zhang Z,Rosenzweig J,et al.Proteomics and bioinformatics approaches for indentification of serum biomarkers to detect breast cancer.Clin Chem,2002,48:1296-1304.
|
| [8] |
Li J,Orlandi R,White CN,et al.Independent validation of candidate breast cancer serum biomarkers identified by mass spectrometry,Clin Chem,2005,51:2229-2235.
|
| [9] |
Goncalves A,Esterni B,Bertucci F,et al.Postoperative serum proteomic profiles may predict metastatic relapse in high-risk primary breast cancer patients receiving adjuvant chemotherapy.Oncogene,2006,25:981-989.
|
| [10] |
Ricolleau G,Charbonnel C,Lode L,et al.Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumors.Proteomics,2006,6:1963-1975.
|